Giuseppe Saglio

54.1k total citations · 7 hit papers
650 papers, 25.0k citations indexed

About

Giuseppe Saglio is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Giuseppe Saglio has authored 650 papers receiving a total of 25.0k indexed citations (citations by other indexed papers that have themselves been cited), including 501 papers in Hematology, 416 papers in Genetics and 153 papers in Rheumatology. Recurrent topics in Giuseppe Saglio's work include Chronic Myeloid Leukemia Treatments (394 papers), Chronic Lymphocytic Leukemia Research (310 papers) and Eosinophilic Disorders and Syndromes (149 papers). Giuseppe Saglio is often cited by papers focused on Chronic Myeloid Leukemia Treatments (394 papers), Chronic Lymphocytic Leukemia Research (310 papers) and Eosinophilic Disorders and Syndromes (149 papers). Giuseppe Saglio collaborates with scholars based in Italy, United States and Germany. Giuseppe Saglio's co-authors include Andreas Hochhaus, Hagop M. Kantarjian, Timothy P. Hughes, Michele Baccarani, Daniela Cilloni, Fabrizio Pane, Giovanni Martinelli, Richard A. Larson, Jörge E. Cortes and Enrico Gottardi and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Giuseppe Saglio

639 papers receiving 24.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

2010 1.2k citations Giuseppe Saglio, Dong‐Wook Kim et al. profile →
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

2003 1.1k citations Fabrizio Pane, Giuseppe Saglio et al. Leukemia profile →
Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

2009 890 citations Michele Baccarani, Jörge E. Cortes et al. Journal of Clinical Oncology profile →
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

1999 865 citations Giuseppe Saglio, Enrico Gottardi et al. Leukemia profile →
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

2003 656 citations Enrico Gottardi, Giuseppe Saglio et al. Leukemia profile →
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

2016 621 citations Jörge E. Cortes, Giuseppe Saglio et al. Journal of Clinical Oncology profile →
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

2016 563 citations Andreas Hochhaus, Giuseppe Saglio et al. Leukemia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giuseppe Saglio Italy	75	18.5k	13.4k	7.0k	5.6k	4.3k	650	25.0k
Michele Baccarani Italy	80	20.3k 1.1×	14.6k 1.1×	8.1k 1.2×	4.9k 0.9×	5.9k 1.4×	711	29.1k
Stefan Faderl United States	88	17.0k 0.9×	10.9k 0.8×	3.5k 0.5×	8.2k 1.5×	5.3k 1.2×	570	27.0k
Elias Jabbour United States	80	18.1k 1.0×	9.4k 0.7×	3.9k 0.6×	6.9k 1.2×	6.1k 1.4×	1.2k	25.4k
Srđan Verstovšek United States	84	18.6k 1.0×	18.7k 1.4×	8.5k 1.2×	12.1k 2.2×	4.4k 1.0×	1.1k	30.0k
Mario Cazzola Italy	73	17.6k 1.0×	15.1k 1.1×	4.4k 0.6×	9.2k 1.6×	2.3k 0.5×	428	25.3k
Deborah A. Thomas United States	80	12.3k 0.7×	10.2k 0.8×	2.6k 0.4×	6.3k 1.1×	4.9k 1.1×	451	23.2k
Zeev Estrov United States	82	13.3k 0.7×	10.5k 0.8×	2.4k 0.3×	11.7k 2.1×	4.8k 1.1×	669	26.3k
Gautam Borthakur United States	65	13.2k 0.7×	6.5k 0.5×	2.4k 0.3×	6.7k 1.2×	2.9k 0.7×	809	17.7k
Farhad Ravandi United States	90	24.8k 1.3×	10.4k 0.8×	2.3k 0.3×	13.0k 2.3×	7.5k 1.7×	1.3k	34.7k
Oliver G. Ottmann Germany	62	10.4k 0.6×	5.0k 0.4×	2.8k 0.4×	4.9k 0.9×	4.0k 0.9×	372	16.1k

Countries citing papers authored by Giuseppe Saglio

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Saglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Saglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Saglio more than expected).

Fields of papers citing papers by Giuseppe Saglio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Saglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Saglio. The network helps show where Giuseppe Saglio may publish in the future.

Co-authorship network of co-authors of Giuseppe Saglio

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Saglio. A scholar is included among the top collaborators of Giuseppe Saglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Saglio. Giuseppe Saglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saglio, Giuseppe, et al.. (2025). A deep dive into the surgical and pharmacological considerations of obesity in chronic myeloid leukemia: a narrative review. Frontiers in Oncology. 15. 1616883–1616883.

Saglio, Giuseppe, Mohamed A. Yassin, Ahmad Alhuraiji, et al.. (2024). Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion. Cancers. 16(11). 2114–2114.

Panuzzo, Cristina, et al.. (2023). CML-076 The Downregulation of Both Large E3 Ubiquitin Ligases, HERC1 and HERC2, is a Common and Unambiguous Feature of Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 23. S332–S333. 1 indexed citations

Gaidano, Valentina, Alessandro Cignetti, Giuseppina Prato, et al.. (2020). A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning. Cancers. 12(6). 1684–1684. 25 indexed citations

Carrà, Giovanna, Paola Circosta, Mara Brancaccio, et al.. (2019). Inhibition of bromodomain and extra‐terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia. Journal of Cellular and Molecular Medicine. 24(2). 1650–1657. 16 indexed citations

Houshmand, Mohammad, Giorgia Simonetti, Paola Circosta, et al.. (2019). Chronic myeloid leukemia stem cells. Leukemia. 33(7). 1543–1556. 131 indexed citations

Carrà, Giovanna, Cristina Panuzzo, Deborah Morena, et al.. (2017). BET Inhibitors in Chronic Lymphocytic Leukemia: JQ1 Synergizes with Venetoclax in Promoting Apoptosis. Blood. 130. 2542. 3 indexed citations

Cortes, Jörge E., Giuseppe Saglio, Hagop M. Kantarjian, et al.. (2016). Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial. Journal of Clinical Oncology. 34(20). 2333–2340. 621 indexed citations breakdown →

Morotti, Alessandro, Sabrina Crivellaro, Cristina Panuzzo, et al.. (2016). IκB-α: At the crossroad between oncogenic and tumor-suppressive signals. Oncology Letters. 13(2). 531–534. 24 indexed citations

10.

Cilloni, Daniela, Sonia Carturan, Enrico Bracco, et al.. (2013). Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia. Leukemia Research. 37(5). 520–530. 13 indexed citations

11.

Goh, Hyun‐Gyung, Min Lin, Takashi Fukushima, et al.. (2011). Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay. Leukemia & lymphoma. 52(5). 896–904. 80 indexed citations

12.

Volpe, Gisella, Cristina Panuzzo, Donatella Lattuada, et al.. (2011). Characterization of a Monoclonal Antibody Specific for Novel Bcr/Abl Out-of-Frame Fusion Proteins. Hybridoma. 30(3). 261–269. 2 indexed citations

13.

Martinelli, Giovanni, Ilaria Iacobucci, Clelia Tiziana Storlazzi, et al.. (2009). IKZF1 (Ikaros) Deletions in BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report. Journal of Clinical Oncology. 27(31). 5202–5207. 219 indexed citations

14.

Hughes, Timothy P., Giuseppe Saglio, Susan Branford, et al.. (2009). Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase. Journal of Clinical Oncology. 27(25). 4204–4210. 236 indexed citations

15.

Messa, Emanuela, Daniela Cilloni, & Giuseppe Saglio. (2007). A young man with persistent eosinophilia. Internal and Emergency Medicine. 2(2). 107–112. 2 indexed citations

16.

Morotti, Alessandro, Daniela Cilloni, Marisa Pautasso, et al.. (2006). NF‐kB inhibition as a strategy to enhance etoposide‐induced apoptosis in K562 cell line. American Journal of Hematology. 81(12). 938–945. 37 indexed citations

17.

Messa, F., Enrico Gottardi, Alessandro Morotti, et al.. (2002). The quantitaive assessment of WT1 gene expression as a method to predict response to STI571 therapy in CML patients. Blood. 1 indexed citations

18.

Scaravaglio, Patrizia, Tommasina Guglielmelli, Emilia Giugliano, et al.. (2002). Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation. Cancer Genetics and Cytogenetics. 133(1). 98–101. 6 indexed citations

19.

Giannini, Barbara, Vittorio Montefusco, Nicoletta Testoni, et al.. (2000). Real-time quantification of different types of BcrAbl transcript in chronic myeloid leukemia. Blood. 96. 16 indexed citations

20.

Dati, Claudio, Susanna Antoniotti, Isabelle Perroteau, et al.. (1991). c‐erbB‐2 and ras expression levels in breast cancer are correlated and show a co‐operative association with unfavorable clinical outcome. International Journal of Cancer. 47(6). 833–838. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact